Orapaz Kit
Product Images NDC 73614-417

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Orapaz (NDC 73614-417). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Brisk Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Box (Orapaz Box)

FDA Label Image

Ceph (Cephalexin Bottle)

FDA Label Image

Chlorhex (Chlorhex Bottle Green)

Chlorhex (Chlorhex Bottle Green)
This is a description of Chlorhexidine Gluconate oral rinse, containing 0.12% Chlorhexidine for dental hygiene. It provides directions for use to swish in the mouth for 30 seconds, then spit out. It includes information on ingredients, such as alcohol, glycerin, and flavor, and storage instructions. The oral rinse is repackaged and distributed by Brisk Pharmaceuticals.*
FDA Label Image

Ibu (Ibu Bottle Green)

Ibu (Ibu Bottle Green)
This is a description of Ibuprofen film-coated tablets, each containing 800 mg of Ibuprofen, USP. The medication bottle is intended for distribution only as part of the branded ORAPAZ™ pack. The tablets are repackaged by a company based in Morrisville, NC and distributed by Brisk Pharmaceuticals, located in Richardson, TX. The recommended storage temperature is between 20°C - 26°C (68°F - 77°F) and should be kept out of reach of children. Each bottle contains 30 tablets and prescription is required for purchase.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.